A recombined fusion protein PTD-Grb2-SH2 inhibits the proliferation of breast cancer cells in vitro
Open Access
- 10 January 2013
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 42 (3) , 1061-1069
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 34 references indexed in Scilit:
- A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFκB activityMolecular Cancer, 2009
- Engineering, cloning, and functional characterization of recombinant LIM mineralization protein-1 containing an N-terminal HIV-derived membrane transduction domainProtein Expression and Purification, 2009
- Short-hairpin RNA-mediated stable silencing of Grb2 impairs cell growth and DNA synthesisBiochemical and Biophysical Research Communications, 2007
- Key cancer cell signal transduction pathways as therapeutic targetsEuropean Journal of Cancer, 2006
- Phosphotyrosine interactome of the ErbB‐receptor kinase familyMolecular Systems Biology, 2005
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast CarcinomaClinical Cancer Research, 2004
- In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the MouseScience, 1999
- The Grb2 adaptorFEBS Letters, 1995
- Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with neuJournal of Steroid Biochemistry, 1989
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970